title: Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.
authors.forename: H P
authors.initials: HP
authors.lastname: Upadhyaya
authors.forename: K T
authors.initials: KT
authors.lastname: Brady
authors.forename: G
authors.initials: G
authors.lastname: Sethuraman
authors.forename: S C
authors.initials: SC
authors.lastname: Sonne
authors.forename: R
authors.initials: R
authors.lastname: Malcolm
mesh_terms: D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D019970:Cocaine-Related Disorders / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D003511:Cyclohexanols / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010865:Pilot Projects; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride